Should polymyxin be used empirically to treat infections in patients under high risk for carbapenem-resistant Acinetobacter?

Should polymyxin be used empirically to treat infections in patients under high risk for carbapenem-resistant Acinetobacter?

Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Journal of Infection - Volume 62, Issue 3, March 2011, Pages 246-249

Felipe F. Tuon, Andrea M. Rymsza, Sergio R. Penteado-Filho, Marcelo Pilonetto, Lavinia N. Arend, Anna S. Levin,